Literature DB >> 26019029

Inter and intrapatient evolution of hepatitis C virus.

Federico A Di Lello1, Andrés C A Culasso2, Rodolfo H Campos2.   

Abstract

Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because evolution can be visualized in real-time. In this review, we discuss the implications to study HCV evolution at the interpatient and intrapatient levels of infection. The HCV interpatient dynamics is relatively slow, because the generation time is generally long. Then, at population level, the HCV diversity originated by the high mutation and replication rates is modulated by the bottleneck at transmission. Thus, when the virus is transmitted to other hosts, viral diversity is reduced as a result of the founder effect. On the other hand, during intrapatient infection, HCV evolves rapidly, resulting in quasispecies. Accumulated evidence suggests that this quasispecies composition of the HCV population within the same individual may allow the virus to evade the immune response or escape treatment, leading to chronic infection. Thus, a better understanding of the complexities underlying the molecular evolution of HCV in natural populations is needed before accurate predictions of viral evolution can be made. In summary, HCV evolves both within and among patients. Consequently, HCV evolution should be studied at both levels in order to better understand the natural history of the virus and its potential implications in epidemiology, outcome of infection and progression of liver disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26019029

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  5 in total

1.  Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencing.

Authors:  Kozue Yamauchi; Mitsuaki Sato; Leona Osawa; Shuya Matsuda; Yasuyuki Komiyama; Natsuko Nakakuki; Hitomi Takada; Ryo Katoh; Masaru Muraoka; Yuichiro Suzuki; Akihisa Tatsumi; Mika Miura; Shinichi Takano; Fumitake Amemiya; Mitsuharu Fukasawa; Yasuhiro Nakayama; Tatsuya Yamaguchi; Taisuke Inoue; Shinya Maekawa; Nobuyuki Enomoto
Journal:  Hepatol Commun       Date:  2022-03-31

2.  Deep sequencing is an appropriate tool for the selection of unique Hepatitis C virus (HCV) variants after single genomic amplification.

Authors:  Thibault Guinoiseau; Alain Moreau; Guillaume Hohnadel; Nicole Ngo-Giang-Huong; Celine Brulard; Patrick Vourc'h; Alain Goudeau; Catherine Gaudy-Graffin
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

3.  Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center.

Authors:  Kamila Caraballo Cortes; Magdalena Rosińska; Maciej Janiak; Małgorzata Stępień; Osvaldo Zagordi; Karol Perlejewski; Sylwia Osuch; Agnieszka Pawełczyk; Iwona Bukowska-Ośko; Rafał Płoski; Piotr Grabarczyk; Tomasz Laskus; Marek Radkowski
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

4.  Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.

Authors:  Debra Van Egeren; Alexander Novokhodko; Madison Stoddard; Uyen Tran; Bruce Zetter; Michael Rogers; Bradley L Pentelute; Jonathan M Carlson; Mark Hixon; Diane Joseph-McCarthy; Arijit Chakravarty
Journal:  PLoS One       Date:  2021-04-28       Impact factor: 3.240

5.  Comparative Analysis of Within-Host Mutation Patterns and Diversity of Hepatitis C Virus Subtypes 1a, 1b, and 3a.

Authors:  Kaho H Tisthammer; Weiyan Dong; Jeffrey B Joy; Pleuni S Pennings
Journal:  Viruses       Date:  2021-03-19       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.